BioTech/Drugs - Jacksonville, FL, US
Cleveland Diabetes Care is focused on Endocrinology and Metabolism systems within the Diabetes disease pharmaceutical market. Diabetes is a medical subspecialty devoted to understanding liver, pancreas, kidneys, and perceptual symptoms resulting from circuit-specific endocrinology and metabolism dysfunction and includes a range of serious diseases and conditions. The Cleveland Diabetes Care pipeline will initially target the treatment of diabetes, endocrinology, and metabolic diseases. Diabetes affects millions of people around the world. Currently available treatment options for these conditions are known to have significant limitations that can result in high rates of therapy discontinuation and unsatisfactory efficacy and safety profiles. Family members also often face significant challenges associated with the burden of these and many other endocrinology and metabolic diseases. Cleveland Diabetes Care is pursuing the development of new therapeutic options based on its deep knowledge of the pathology of endocrinology and metabolism diseases, the pharmacology of its library of compounds, and its understanding of desired outcomes for unmet patient needs. Our product candidates each have novel mechanisms of action and represent differentiated treatment options with the potential to address unmet needs with significantly improved efficacy and safety.
Ubuntu
WordPress.org
Typekit
Amazon AWS
Mobile Friendly